Home page Home page

Dicural
difloxacin

42

Medicinal product no longer authorised


PACKAGE LEAFLET FOR

Dicural 100 mg/ml oral solution for chickens and turkeys


authorised

  1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE


    Marketing authorisation holder

    Pfizer Limited Ramsgate Road Sandwich

    Kent CT13 9NJ

    United Kingdom


    Manufacturer for the batch release

    Pfizer Olot, S.L.U.

    Ctra. Camprodón, s/n°, Finca La Riba, Vall de Bianya, 17813 Girona

    Spain


  2. NAME OF THE VETERINARY MEDICINAL PRODUCT


    Dicural 100 mg/ml oral solution for chickens and turkeys


    no

  3. STATEMENT OF THE ACTIVE SUBSTANCE AND OTHER INGREDIENT(S)


    Each ml contains:


    Active substance

    Difloxacin (as hydrochloride) 100 mg


    Excipients


    Other excipients, including benzyl alcohol, in an aqueous formulation to 1 ml


    Medicinal

  4. INDICATIONS


    In chickens and turkeys: Dicural oral solution is indicated for treatment of chronic respiratory infections caused by sensitive strains of Escherichia coli and Mycoplasma gallisepticum.


    In turkeys: Dicural oral solution is also indicated for the treatment of infections caused by Pasteurella multocida.


    Dicural oral solution should only be used based on susceptibility testing


  5. CONTRAINDICATIONS


    Since no studies were performed in clinically lame birds, Dicural oral solution should not be used in birds with existing leg-weakness or in birds suffering from osteoporosis.

  6. ADVERSE REACTIONS


    If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon.


    authorised

  7. TARGET SPECIES


    Chickens (broilers and future breeders)

    Turkeys (young turkeys up to 2 kg body weight).


  8. DOSAGE FOR EACH SPECIES, METHOD AND ROUTE OF ADMINISTRATION


    Dicural oral solution must be administrated daily via the drinking water in such a concentration that the dose is 10 mg/kg bodyweight. The administration must be continued for 5 days.


    For oral administration in drinking water.


    Taking into account the content of difloxacin in the oral solution (10%w/v), the following calculation should be made to determine the volume (ml) to be added for each 1000 litres of water:


    number of animals in the house X mean weight of individual animal(kg) X 100

    -----------------------------------------------------------------------------------------------------

    total water consumption of the house at the previous day (litres)


    no

  9. ADVICE ON CORRECT ADMINISTRATION


    The screw cap on the 1 litre bottle can be used as measuring device. If filled to the brim the measuring device provides 50 ml. For the 250 ml bottle a separate measuring device is placed on the screw cap. Measuring lines indicate the volume supplied.


    The medicated drinking water should be prepared freshly each day.


    No other source of drinking water should be available during the medication period.


    Medicinal

    No additional chlorine, for example from the use of water chlorinators, or hydrogen peroxide should be added to the drinking water used with this product.


    At concentrations in the water of 0.03% (= 300 ml in 1000 litres) or greater, palatability for turkeys may be affected.


  10. WITHDRAWAL PERIODS


    Meat and offal (chicken and turkeys): 24 hours.


    Not permitted for use in laying birds producing eggs for human consumption.


  11. SPECIAL STORAGE PRECAUTIONS

    Keep out of the reach and sight of children. Do not store above 25 °C.

    Protect from light.

    Do not freeze.


    Shelf-life after first opening the container: 1 month.

    Do not use after the expiry date stated on the label after EXP


    authorised

  12. SPECIAL WARNING(S)


    Do not use in birds in lay and/or within 4 weeks before the onset of the laying period.>


    Heavy reliance on a single class of antibiotics may result in the induction of resistance in a bacterial population. It is prudent to reserve the fluoroquinolones for the treatment of clinical conditions that have responded poorly, or are expected to respond poorly, to other classes of antibiotic.


    People with known hypersensitivity to quinolones should avoid any contact with the product.

    In order to avoid irritation of skin and/or eyes, use gloves and a face-protecting device, when handling this product.


  13. SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIALS, IF ANY


    Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.


    no

  14. DATE ON WHICH THE PACKAGE LEAFLET WAS LAST REVISED


    Detailed information on this product is available on the website of the European Medicines Agency


  15. OTHER INFORMATION


For animal treatment only. To be supplied only on veterinary prescription.


Medicinal

Dicural oral solution is a yellowish clear aqueous solution and is supplied in plastic white bottles with a screw cap containing 250 or 1000 ml oral solution. Not all pack sizes may be marketed.


For any information about this veterinary medicinal product, please contact the local representative of the marketing authorisation holder.

België/Belgique/Belgien Pfizer Animal Health s.a., Tél.: +32 (0)2 554 62 11

Luxembourg


Pfizer Animal Health s.a., Tél.: + 32 (0)2 554 62 11


Република България Pfizer Luxembourg SARL Tel: + 359 2 970 41 71

authorised

Magyarország Pfizer Kft.

Tel: +361 488 3695


Česká republika Pfizer Animal Health

Tel: +420 283 004 111

Malta


Agrimed Limited Tel: +356 21 465 797


Danmark


Pfizer Oy Animal Health Tlf: +358 (0)9 4300 40

Nederland


Pfizer Animal Health B.V., Tel: +31 (0)10 4064 600


Deutschland Pfizer GmbH

Tel: +49 30-5500 5501

Norge


no

Pfizer Oy Animal Health Tlf: +358 (0)9 4300 40


Eesti


Medicinal

Pfizer Animal Health Tel: +370 5 269 17 96

Österreich


Pfizer Corporation Austria Ges.m.b.H. Tel: +43 (0)1 52 11 57 20


Ελλάδα


Pfizer Hellas A.E.


Τηλ.: +30 210 6785800

Polska


Pfizer Trading Polska Sp. z.o.o. Tel: +48 22 335 61 00


España Pfizer S.L.

Tel: +34 91 4909900

Portugal


Laboratórios Pfizer, Lda. Tel: +351 21 423 55 00

France Pfizer

Tél: +33 (0)1 58 07 46 00

Romania


Pfizer Romania SRL


Tel: + 0040 21 207 28 93


Ireland


Pfizer Healthcare Ireland, trading as: Pfizer Animal Health

Tel: +353 (0) 1 467 6500

authorised

Slovenija


Pfizer Luxembourg SARL Tel: +386 (0) 1 52 11 670


Ìsland


Pfizer Oy Animal Health Tel: +358 (0)9 4300 40

Slovenská republika


Pfizer Luxembourg SARL o.z. Tel: + 421 2 3355 5500


Italia


Pfizer Italia S.r.l.,


Tel: +39 06 3318 2933

Suomi/Finland


no

Pfizer Oy Animal Health, Puh/Tel: +358 (0)9 4300 40


Kύπρος


Pfizer Hellas A.E.


Τηλ.: +30 210 6785800

Sverige


Pfizer Oy Animal Health Tel: +358 (0)9 4300 40


Medicinal

Latvija


Pfizer Animal Health Tel: +370 5 269 17 96

United Kingdom Pfizer Ltd

Tel: +44 (0) 1304 616161


Lietuva


Pfizer Animal Health Tel: +370 5 269 17 96

PACKAGE LEAFLET FOR

Dicural coated tablets for dogs


authorised

  1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE


    Marketing authorisation holder:

    Pfizer Limited Ramsgate Road Sandwich

    Kent CT13 9NJ

    United Kingdom


    Manufacturer for the batch release:

    Pfizer Olot, S.L.U.

    Ctra. Camprodón, s/n°, Finca La Riba, Vall de Bianya, 17813 Girona

    Spain


  2. NAME OF THE VETERINARY MEDICINAL PRODUCT


    no

    Dicural 15 mg coated tablets for dogs Dicural 50 mg coated tablets for dogs Dicural 100 mg coated tablets for dogs Dicural 150 mg coated tablets for dogs


  3. STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S)


    Each tablet contains:

    Dicural 15 mg

    difloxacin (as hydrochloride)

    15 mg

    Dicural 50 mg

    difloxacin (as hydrochloride)

    50 mg

    Dicural 100 mg

    difloxacin (as hydrochloride)

    100 mg

    Dicural 150 mg

    difloxacin (as hydrochloride)

    150 mg


    Medicinal

  4. INDICATION(S)


    Dicural coated tablets are indicated for the following clinical conditions in dogs:

    • Acute uncomplicated urinary tract infections caused by Escherichia coli or Staphylococcus spp.

    • Superficial pyoderma caused by Staphylococcus intermedius.


      Dicural Coated Tablets should only be used based on susceptibility testing.


  5. CONTRAINDICATIONS


    As for other quinolones, due to possible adverse effects on the articular cartilage of weight bearing joints, difloxacin should not be used during the rapid growth phase, that is, do not use in small-and medium breed dogs up to and including 8 months of age, in large breeds up to 1 year of age and in giant breeds up to 18 months of age.


    Do not use in epileptic dogs.

  6. ADVERSE REACTIONS


    authorised

    Adverse reactions were rare in dogs treated with difloxacin. The observed reactions were inappetence, emesis, diarrhoea, and anal irritation. These adverse reactions were self-limiting within one or two days and did not require additional treatment.


    If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon.


  7. TARGET SPECIES


    Dogs


  8. DOSAGE FOR EACH SPECIES, METHOD AND ROUTE(S) OF ADMINISTRATION


    The recommended dose of difloxacin is 5 mg/kg bodyweight per day. Dicural coated tablets should be given once a day for at least 5 days. Superficial pyoderma may require treatment for up to a maximum of 21 days. The tablets should be administered for at least 2 days beyond the cessation of clinical signs.


    no

    Therapy should be re-evaluated if no improvement is seen within 5 days, or 10 days in the case of superficial pyoderma.


    Bodyweight (kg)

    Dicural 15 mg

    Dicural 50 mg

    Dicural 100 mg

    Dicural 150 mg


    Small

    0 - 3

    4 - 6

    1

    2


    Medium

    7 - 10

    11 - 20

    21 - 30

    (3)

    1

    2

    3


    (1)


    (1)


    Large

    31 - 40

    41 - 60

    2

    3


    (2)


    Medicinal

    For oral use.


  9. ADVICE ON CORRECT ADMINISTRATION


  10. WITHDRAWAL PERIOD


    Not applicable.

  11. SPECIAL STORAGE PRECAUTIONS


    Keep out of the reach and sight of children. Do not store above 25°C. Store in a dry place.

    authorised

    Do not use after the expiry date stated on the carton after EXP.


  12. SPECIAL WARNING(S)


    People with known hypersensitivity to quinolones should avoid any contact with the product. The use of difloxacin in pregnant or lactating bitches or male stud dogs is not recommended.


    Heavy reliance on a single class of antibiotics may result in the induction of resistance in a bacterial population. It is prudent to reserve the fluoroquinolones for the treatment of clinical conditions that have responded poorly, or are expected to respond poorly, to other classes of antibiotic.


  13. SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIALS, IF ANY


    Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.


    no

  14. DATE ON WHICH THE PACKAGE LEAFLET WAS LAST REVISED


    Detailed information on this product is available on the website of the European Medicines Agency


  15. OTHER INFORMATION


For animal treatment only - to be supplied only on veterinary prescription.


Medicinal

Dicural coated tablets consist of a core tablet containing difloxacin hydrochloride and a highly palatable coating. Each strength of the product is available in packs of 10, 20 and 100 tablets. Not all pack sizes may be marketed.


Difloxacin is an aryl-fluoroquinolone with a broad spectrum of antimicrobial activity. Difloxacin can be bactericidal against many Gram-negative micro-organisms and a selection of Gram-positive micro- organisms.


The fluoroquinolones exert their antibacterial effects against both replicating and dormant micro- organisms. Difloxacin acts primarily through inhibition of bacterial DNA gyrase.

The following organisms were tested and found to be susceptible to difloxacin in vitro: Escherichia coli

Klebsiella spp.

Pasteurella spp. Pseudomonas spp. Staphylococcus intermedius

The following organisms were found to be of intermediate susceptibility:


authorised

Proteus spp. Staphylococcus spp. Streptococcus canis (beta) Streptococcus spp.


Following an oral dose (a plain tablet) in dogs of 5 mg/kg bodyweight, difloxacin reached its average peak plasma concentration of 1.8 µg/ml in approximately 3 hours. Approximately 95 % of the oral dose was absorbed. The elimination half-life averaged 9.3 hours.


Long term daily oral treatment over 180 days at 5 mg/kg bodyweight did not influence difloxacin kinetics, neither by accumulation nor by increased drug metabolism.


Medicinal

no

For any information about this veterinary medicinal product, please contact the local representative of the Marketing Authorisation Holder.

België/Belgique/Belgien Pfizer Animal Health s.a., Tél.: +32 (0)2 554 62 11

Luxembourg


Pfizer Animal Health s.a., Tél.: + 32 (0)2 554 62 11


Република България Pfizer Luxembourg SARL Tel: + 359 2 970 41 71

authorised

Magyarország Pfizer Kft.

Tel: +361 488 3695


Česká republika Pfizer Animal Health

Tel: +420 283 004 111

Malta


Agrimed Limited Tel: +356 21 465 797


Danmark


Pfizer Oy Animal Health Tlf: +358 (0)9 4300 40

Nederland


Pfizer Animal Health B.V., Tel: +31 (0)10 4064 600


Deutschland Pfizer GmbH

Tel: +49 30-5500 5501

Norge


no

Pfizer Oy Animal Health Tlf: +358 (0)9 4300 40


Eesti


Medicinal

Pfizer Animal Health Tel: +370 5 269 17 96

Österreich


Pfizer Corporation Austria Ges.m.b.H. Tel: +43 (0)1 52 11 57 20


Ελλάδα


Pfizer Hellas A.E.


Τηλ.: +30 210 6785800

Polska


Pfizer Trading Polska Sp. z.o.o. Tel: +48 22 335 61 00


España Pfizer S.L.

Tel: +34 91 4909900

Portugal


Laboratórios Pfizer, Lda. Tel: +351 21 423 55 00

France Pfizer

Tél: +33 (0)1 58 07 46 00

Romania


Pfizer Romania SRL


Tel: + 0040 21 207 28 93


Ireland


Pfizer Healthcare Ireland, trading as: Pfizer Animal Health

Tel: +353 (0) 1 467 6500

authorised

Slovenija


Pfizer Luxembourg SARL Tel: +386 (0) 1 52 11 670


Ìsland


Pfizer Oy Animal Health Tel: +358 (0)9 4300 40

Slovenská republika


Pfizer Luxembourg SARL o.z. Tel: + 421 2 3355 5500


Italia


Pfizer Italia S.r.l.,


Tel: +39 06 3318 2933

Suomi/Finland


no

Pfizer Oy Animal Health, Puh/Tel: +358 (0)9 4300 40


Kύπρος


Pfizer Hellas A.E.


Τηλ.: +30 210 6785800

Sverige


Pfizer Oy Animal Health Tel: +358 (0)9 4300 40


Medicinal

Latvija


Pfizer Animal Health Tel: +370 5 269 17 96

United Kingdom Pfizer Ltd

Tel: +44 (0) 1304 616161


Lietuva


Pfizer Animal Health Tel: +370 5 269 17 96

PACKAGE LEAFLET FOR:

Dicural 50 mg/ml solution for injection for cattle and dogs


authorised

  1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE


    Marketing authorisation holder:

    Pfizer Limited Ramsgate Road Sandwich

    Kent CT13 9NJ

    United Kingdom


    Manufacturer for the batch release:

    Pfizer Olot, S.L.U.

    Ctra. Camprodón, s/n°, Finca La Riba, Vall de Bianya, 17813 Girona

    Spain


  2. NAME OF THE VETERINARY MEDICINAL PRODUCT


    no

    Dicural 50 mg/ml solution for injection for cattle and dogs


  3. STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S)


    Active substance

    Difloxacin (as hydrochloride) 50 mg/ml


    Excipients

    Benzyl alcohol 50 mg/ml


  4. INDICATION(S)


    Medicinal

    Cattle: Treatment of Bovine respiratory disease (shipping fever, calf pneumonia) caused by single or mixed infections with Pasteurella haemolytica, Pasteurella multocida, and/or Mycoplasma spp.


    Dogs: treatment of:

    • Acute uncomplicated urinary tract infections caused by Escherichia coli or Staphylococcus spp

    • Superficial pyoderma caused by Staphylococcus intermedius.


  5. CONTRAINDICATIONS


    Cattle: None.


    Dogs:As for other quinolones, due to possible adverse effects on the articular cartilage of weight bearing joints difloxacin should not be used during the rapid growth phase, that is,. do not use in small and medium-sized breeds of dogs up to and including 8 months of age, in large breeds up to 1 year of age and in giant breeds up to 18 months of age.

    Do not use in epileptic dogs.


  6. ADVERSE REACTIONS


    authorised

    Cattle:

    In target animal safety studies, subcutaneous administration was generally well tolerated. Transient swelling at the injection site following administration may occur.


    Dogs:

    In target animal safety studies, subcutaneous administration was generally well tolerated. Pruritis and/or local swellings and occasionally a slight pain reaction on injection have been observed. In general the pruritis disappears within a few minutes and the local swelling within a few days.


    If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon.


  7. TARGET SPECIES


    Cattle (calves and young cattle)\ Dogs


  8. DOSAGE FOR EACH SPECIES, METHOD AND ROUTE(S) OF ADMINISTRATION


    no

    Subcutaneous use


    Cattle:

    The recommended dose is 2.5 mg difloxacin/kg bodyweight/day for 3 days (that is, 5ml/100 kg bodyweight/day). If there is insufficient improvement after 3 days, the treatment can be continued for another 2 days. For complicated respiratory disease the dose can be doubled to 5 mg/kg bodyweight / day.


    Dogs:

    The recommended dose is 5.0 mg difloxacin/kg body weight in a single injection Treatment should be continued with Dicural coated tablets (read the package leaflet of this product)


    Medicinal

  9. ADVICE ON CORRECT ADMINISTRATION


    In cattle, the volume administered per injection site should not exceed 7 ml. A new injection site should be used each day.


    In dogs, the volume administered per injection site should not exceed 5 ml.


    In the absence of incompatibility studies, this veterinary medicinal product must not be mixed with other veterinary medicinal products.


  10. WITHDRAWAL PERIOD


    Cattle: Meat and offal: 46 days

  11. SPECIAL STORAGE PRECAUTIONS

    authorised

    Keep out of the reach and sight of children. Do not store above 25-C.

    Do not freeze.

    Keep the container in the outer carton.

    Shelf-life after first use of the product: 28 days.

    Do not use after the expiry date stated on the vial after EXP.


  12. SPECIAL WARNING(S)


    Heavy reliance on a single class of antibiotics may result in the induction of resistance in a bacterial population. It is prudent to reserve the fluoroquinolones for the treatment of clinical conditions that have responded poorly, or are expected to respond poorly, to other classes of antibiotic.

    Dicural 50 mg/ml solution for injection should only be used based on susceptibility testing. The safety of the veterinary medicinal product has not been established during pregnancy and

    lactation.

    The use of fluoroquinolones in combination with non-steroidal anti-inflammatory drugs (NSAIDs) may cause seizures.

    Antagonism may be observed with nitrofurantoin.


    no

    People with a known hypersensitivity to quinolones should avoid any contact with the product.

    Overdose Cattle:

    At very high doses adverse effects on the nervous system (ataxia, unsteadiness, twitching, tremors,

    convulsions, etc.) may occur in cattle. Overdosage may also give rise to oedema and swelling in the knee joints.


    Dogs:

    In dogs the oral administration of difloxacin at up to 5 times the recommended dose rate for 30 days did not result in any adverse reactions.


    Medicinal

    In another study dogs treated orally with difloxacin at 10 times the recommended dose for 10 days showed occasionally mild adverse reactions such as orange/yellowing discoloration of the faeces, emesis and hypersalivation.


    No specific antidotes for difloxacin (or other quinolones) are known, therefore in case of overdosage symptomatic treatment should be given


  13. SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIALS, IF ANY


    Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

  14. DATE ON WHICH THE PACKAGE LEAFLET WAS LAST REVISED


    authorised

    Detailed information on this product is available on the website of the European Medicines Agency


  15. OTHER INFORMATION


For animal treatment only. To be supplied only on veterinary prescription.


Dicural 50 mg/ml, solution for injection for cattle and dogs is available in the following presentations: Dogs: 50 ml vial.

Cattle: 50, 100 and 250 ml vials. Not all pack sizes may be marketed.


Medicinal

no

For any information about this veterinary medicinal product, please contact the local representative of the Marketing Authorisation Holder.

België/Belgique/Belgien Pfizer Animal Health s.a., Tél.: +32 (0)2 554 62 11

Luxembourg


Pfizer Animal Health s.a., Tél.: + 32 (0)2 554 62 11


Република България Pfizer Luxembourg SARL Tel: + 359 2 970 41 71

authorised

Magyarország Pfizer Kft.

Tel: +361 488 3695


Česká republika Pfizer Animal Health

Tel: +420 283 004 111

Malta


Agrimed Limited Tel: +356 21 465 797


Danmark


Pfizer Oy Animal Health Tlf: +358 (0)9 4300 40

Nederland


Pfizer Animal Health B.V., Tel: +31 (0)10 4064 600


Deutschland Pfizer GmbH

Tel: +49 30-5500 5501

Norge


no

Pfizer Oy Animal Health Tlf: +358 (0)9 4300 40


Eesti


Medicinal

Pfizer Animal Health Tel: +370 5 269 17 96

Österreich


Pfizer Corporation Austria Ges.m.b.H. Tel: +43 (0)1 52 11 57 20


Ελλάδα


Pfizer Hellas A.E.


Τηλ.: +30 210 6785800

Polska


Pfizer Trading Polska Sp. z.o.o. Tel: +48 22 335 61 00


España Pfizer S.L.

Tel: +34 91 4909900

Portugal


Laboratórios Pfizer, Lda. Tel: +351 21 423 55 00

France Pfizer

Tél: +33 (0)1 58 07 46 00

Romania


Pfizer Romania SRL


Tel: + 0040 21 207 28 93


Ireland


Pfizer Healthcare Ireland, trading as: Pfizer Animal Health

Tel: +353 (0) 1 467 6500

authorised

Slovenija


Pfizer Luxembourg SARL Tel: +386 (0) 1 52 11 670


Ìsland


Pfizer Oy Animal Health Tel: +358 (0)9 4300 40

Slovenská republika


Pfizer Luxembourg SARL o.z. Tel: + 421 2 3355 5500


Italia


Pfizer Italia S.r.l.,


Tel: +39 06 3318 2933

Suomi/Finland


no

Pfizer Oy Animal Health, Puh/Tel: +358 (0)9 4300 40


Kύπρος


Pfizer Hellas A.E.


Τηλ.: +30 210 6785800

Sverige


Pfizer Oy Animal Health Tel: +358 (0)9 4300 40


Medicinal

Latvija


Pfizer Animal Health Tel: +370 5 269 17 96

United Kingdom Pfizer Ltd

Tel: +44 (0) 1304 616161


Lietuva


Pfizer Animal Health Tel: +370 5 269 17 96